Improving cancer treatment for older veterans with multiple myeloma by assessing their overall health.

Integration of Geriatric Measures Alongside Disease-Based Measures to Advance Precision Oncology for Older Veterans with Multiple Myeloma

NIH-funded research VA Boston Health Care System · NIH-10975943

This study is looking to improve cancer treatment for older veterans with multiple myeloma by combining regular health check-ups with cancer tests, so they can get personalized care that fits their unique health needs.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVA Boston Health Care System NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-10975943 on NIH RePORTER

What this research studies

This research aims to enhance cancer treatment for older veterans diagnosed with multiple myeloma by integrating geriatric assessments alongside traditional disease-based measures. The study will electronically evaluate frailty and multimorbidity in over 5,000 veterans aged 65 and older using existing healthcare data from the VA's integrated health system. By focusing on both the genetic profile of the cancer and the overall health of the patient, the research seeks to develop personalized treatment strategies that consider the unique needs of older adults. The approach leverages electronic health records to streamline the assessment process, making it feasible for busy oncology clinics.

Who could benefit from this research

Good fit: Ideal candidates for this research are veterans aged 65 and older who have been newly diagnosed with multiple myeloma.

Not a fit: Patients who are younger than 65 or do not have a diagnosis of multiple myeloma may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more tailored and effective cancer treatments for older veterans, improving their overall health outcomes.

How similar studies have performed: Other research has shown promising results in integrating geriatric assessments into oncology, indicating that this approach could be effective.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.